Related references
Note: Only part of the references are listed.Targeting IL-10 Family Cytokines for the Treatment of Human Diseases
Xiaoting Wang et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2019)
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Wenjun Ouyang et al.
IMMUNITY (2019)
The Neonatal Fc Receptor (FcRn): A Misnomer?
Michal Pyzik et al.
FRONTIERS IN IMMUNOLOGY (2019)
F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET Guided Translational Approach
Stefan T. G. Bruijnen et al.
MOLECULAR PHARMACEUTICS (2019)
Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism
Yannick Degboe et al.
FRONTIERS IN IMMUNOLOGY (2019)
Inflammation and Lymphatic Function
Simon Schwager et al.
FRONTIERS IN IMMUNOLOGY (2019)
Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis
Jan Piet van Hamburg et al.
JOURNAL OF AUTOIMMUNITY (2018)
An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells
Peng Wang et al.
THERANOSTICS (2018)
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Qiang Guo et al.
BONE RESEARCH (2018)
Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury
Michal Pyzik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
Guizhi Zhu et al.
NATURE COMMUNICATIONS (2017)
The Plasticity of Th17 Cells in the Pathogenesis of Rheumatoid Arthritis
Shigeru Kotake et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab
Isabelle Cludts et al.
CYTOKINE (2017)
Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review
Colum Downey
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy
Ankit Saxena et al.
CYTOKINE (2015)
Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS
Sharad K. Mittal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
Brian Ruffell et al.
CANCER CELL (2014)
Infection risk in patients with rheumatoid arthritis treated with etanercept or adalimumab
Yi-Chun Chiang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2014)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse
Fabia Doll et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Effects of PEGylation and Immune Complex Formation on the Pharmacokinetics and Biodistribution of Recombinant Interleukin 10 in Mice
Hamsell M. Alvarez et al.
DRUG METABOLISM AND DISPOSITION (2012)
A case of adalimumab-induced pneumonitis in a 45-year-old man with Crohn's disease
James D. Reid et al.
CANADIAN RESPIRATORY JOURNAL (2011)
Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3- and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner
Samuel Huber et al.
IMMUNITY (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Visualizing vascular permeability and lymphatic drainage using labeled serum albumin
Katrien Vandoorne et al.
ANGIOGENESIS (2010)
Enhanced antibody half-life improves in vivo activity
Jonathan Zalevsky et al.
NATURE BIOTECHNOLOGY (2010)
Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
Kathrin Schwager et al.
ARTHRITIS RESEARCH & THERAPY (2009)
IL-10: The master regulator of immunity to infection
Kevin N. Couper et al.
JOURNAL OF IMMUNOLOGY (2008)
Collagen antibody-induced arthritis
Levon M. Khachigian
NATURE PROTOCOLS (2006)
Effect of albumin fusion on the biodistribution of interleukin-2
ZS Yao et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Lymphocyte trafficking across high endothelial venules: Dogmas and enigmas
M Miyasaka et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Interleukin-10 therapy - Review of a new approach
K Asadullah et al.
PHARMACOLOGICAL REVIEWS (2003)
Evolving concepts of rheumatoid arthritis
GS Firestein
NATURE (2003)
Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate - The ARMADA trial
ME Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2003)